Awards & Recognition
★Chief Executive Magazine's 2025 CEO of the Year
★Watanabe Award winner (2024)
★Named to STAT News STATUS List 2025
Notable Facts
→Chairman and CEO of Eli Lilly since 2017, world's most valuable pharmaceutical company by market cap
→Led company transformation with GLP-1 drugs (Mounjaro, Zepbound) for diabetes and obesity
→Under his leadership, Lilly grew from $70B to near $700B market cap
→Serves on Adobe board of directors and Business Roundtable
→25+ year Lilly veteran who started as business development associate in 1996
→Led breakthrough Alzheimer's drug development (Kisunla/donanemab)
→Reduced insulin prices by 70% industry-leading move
→Building AI supercomputer with NVIDIA for drug discovery